SCHEMBL20179330

SCHEMBL20179330

CC(CC(C)(C)C)c1ccc(OCC(=O)Nc2ccc(CC(=O)NO)cc2)cc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.52
NPC1 O15118 1/20 0.51
RAB9A P51151 1/20 0.51
SMN1; SMN2 Q16637 3/20 0.50
MEN1 O00255 3/20 0.50
KMT2A Q03164 3/20 0.50
HDAC10 Q969S8 2/20 0.48
HDAC6 Q9UBN7 2/20 0.48
HDAC3 O15379 1/20 0.48
HDAC4 P56524 1/20 0.48
HDAC1 Q13547 1/20 0.48
HDAC7 Q8WUI4 1/20 0.48
HDAC2 Q92769 1/20 0.48
HDAC11 Q96DB2 1/20 0.48
HDAC8 Q9BY41 1/20 0.48
HDAC9 Q9UKV0 1/20 0.48
HDAC5 Q9UQL6 1/20 0.48
MAPT P10636 4/20 0.47
KDM4E B2RXH2 2/20 0.46
CYP1A2 P05177 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20179130 0.83 HDAC1 (0.55) ALDH1A1NPC1RAB9AHDAC10HDAC6
SCHEMBL20179233 0.80 MEN1 (0.68) SMN1; SMN2MEN1KMT2AHDAC10HDAC6
SCHEMBL12688128 0.77 TDP1 (0.62) NPC1RAB9ASMN1; SMN2MEN1KMT2A
SCHEMBL4639940 0.75 NPC1 (0.57) ALDH1A1NPC1RAB9ASMN1; SMN2MEN1
SCHEMBL20163302 0.74 SMN1; SMN2 (0.62) ALDH1A1NPC1RAB9ASMN1; SMN2MEN1
SCHEMBL11961003 0.70 NPC1 (0.69) ALDH1A1NPC1RAB9ASMN1; SMN2MAPT
SCHEMBL12687868 0.70 HDAC6 (0.58) NPC1RAB9ASMN1; SMN2MEN1KMT2A
SCHEMBL5432031 0.69 ALDH1A1 (0.77) ALDH1A1NPC1RAB9ASMN1; SMN2MEN1
SCHEMBL19845882 0.69 HDAC6 (0.65) SMN1; SMN2MEN1KMT2AHDAC10HDAC6
SCHEMBL31503974 0.69 TRPV1 (0.70) ALDH1A1SMN1; SMN2MEN1KMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180141965-A1 AUTOTAXIN INHIBITORS AND USES THEREOF NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS (GR) 2018-05-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180141965-A1 AUTOTAXIN INHIBITORS AND USES THEREOF ENPP2, SPINT2, SERPINB1 ALDH1A1 4218/4885NPC1 3987/4885RAB9A 2872/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.